Status:
RECRUITING
The MR-Linac Technical Feasibility Protocol
Lead Sponsor:
The Netherlands Cancer Institute
Collaborating Sponsors:
Elekta Limited
Conditions:
Tumors at All Sites Which Will Receive Radiotherapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Radiation therapy is predominantly based on a Computed Tomography (CT) scan obtained during the treatment planning phase. During the course of radiotherapy, however, both the tumor and organs at risk ...
Detailed Description
The proposed protocol aims to determine feasibility of multiple new techniques and software for MR-guided adaptive radiation therapy. For each proposed technique feasibility has to be determined indiv...
Eligibility Criteria
Inclusion
- Patient, age ≥ 18 years, treated with radiation therapy on the MRL.
- WHO performance 0-2.
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Contra-indications for an MRI examination.
- Patient is pregnant.
- Claustrophobia.
- Patients \>140 kg and/or a body width \> 60 cm.
- Patients with any other clinically significant medical condition which, in the opinion of the treating physician, makes it undesirable for the patient to participate in the study or which could jeopardize compliance with study requirements or severe psychiatric illness/social situation.
Key Trial Info
Start Date :
January 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04351204
Start Date
January 22 2019
End Date
July 1 2026
Last Update
February 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, Netherlands, 1066CX